Literature DB >> 26722563

Genetic association of cyclooxygenase-2 gene polymorphisms with Parkinson's disease susceptibility in Chinese Han population.

Yi Dai1, Yuquan Wu2, Yansheng Li3.   

Abstract

OBJECTIVE: The aim of this study was to explore the genetic association of cyclooxygenase-2 (COX2) gene promoter region polymorphisms with Parkinson's disease (PD) susceptibility in Chinese Han population.
METHODS: The genotyping of COX2 gene polymorphisms was conducted by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 122 patients with PD and 120 healthy persons. The association strength of gene polymorphism with disease was measured by odds ratio (OR) and 95% confidence interval (95% CI) calculated using χ(2) test which also evaluated the Hardy-Weinberg equilibrium (HWE) of gene polymorphism in controls. The linkage disequilibrium and haplotype were also analyzed as evidence in the analysis of association.
RESULTS: On condition that the genotypes distributions of COX2 -1290A>G, -1195G>A, -765G>C in the control group all conformed to HWE, however, only the homozygous genotype AA of -1195G>A polymorphism showed an association with PD (OR=0.432, 95% CI=0.196-0.950). In addition, in haplotype analysis, G-A-C haplotype frequency in cases was significantly lower than the controls, compared with the common haplotype A-G-G (P=0.031, OR=0.375, 95% CI=0.149-0.940).
CONCLUSIONS: COX2 -1195G>A polymorphism might play a protective role in the onset of PD and G-A-C haplotype in this three promoter region polymorphisms also showed a negative association.

Entities:  

Keywords:  Cyclooxygenase-2; parkinson’s disease; polymorphism; promoter

Mesh:

Substances:

Year:  2015        PMID: 26722563      PMCID: PMC4680508     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  Problem situations in the treatment of paralysis agitans.

Authors:  L J DOSHAY
Journal:  J Am Med Assoc       Date:  1954-10-16

Review 2.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.

Authors:  K Ray Chaudhuri; Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

Review 3.  Genetics of Parkinson disease.

Authors:  Nathan Pankratz; Tatiana Foroud
Journal:  NeuroRx       Date:  2004-04

4.  Genes and parkinsonism.

Authors:  N Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

5.  Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.

Authors:  Xuemei Zhang; Xiaoping Miao; Wen Tan; Baitang Ning; Zhihua Liu; Yuan Hong; Wenguang Song; Yongli Guo; Xinyu Zhang; Yan Shen; Boqin Qiang; Fred F Kadlubar; Dongxin Lin
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

6.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 7.  Epidemiology of Parkinson's disease.

Authors:  Lonneke M L de Lau; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

8.  [Ginsenoside Rg1 modulates COX-2 expression in the substantia nigra of mice with MPTP-induced Parkinson disease through the P38 signaling pathway].

Authors:  Qian Wang; Huan Zheng; Zuo-feng Zhang; Yu-xin Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2008-08

9.  Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.

Authors:  Selvaraju Veeriah; Barry S Taylor; Shasha Meng; Fang Fang; Emrullah Yilmaz; Igor Vivanco; Manickam Janakiraman; Nikolaus Schultz; Aphrothiti J Hanrahan; William Pao; Marc Ladanyi; Chris Sander; Adriana Heguy; Eric C Holland; Philip B Paty; Paul S Mischel; Linda Liau; Timothy F Cloughesy; Ingo K Mellinghoff; David B Solit; Timothy A Chan
Journal:  Nat Genet       Date:  2009-11-29       Impact factor: 38.330

Review 10.  Genetics of Parkinson's disease.

Authors:  T Gasser
Journal:  Ann Neurol       Date:  1998-09       Impact factor: 10.422

View more
  1 in total

Review 1.  Chronic Inflammation Links Cancer and Parkinson's Disease.

Authors:  Zhiming Li; Zaozao Zheng; Jun Ruan; Zhi Li; Chi-Meng Tzeng
Journal:  Front Aging Neurosci       Date:  2016-06-03       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.